Desmin tyrosine phosphorylated mutant and pancreatic cancer
AssigneesKendrick Laboratories, Inc., Clarkson University
InventorsNancy KENDRICK, Jon JOHANSEN, Matt HOELTER, Andrew KOLL, Costel C. DARIE
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for detecting a mutant desmin protein comprising a phosphorylated D399Y mutation. In some embodiments, the methods are used to diagnose cancer in a subject. Also provided are compositions comprising or constructs encoding a fragment of the mutant desmin protein with a phosphorylated tyrosine residue at position 399 corresponding to a D399Y mutation and methods of using these compositions to treat cancer.
Claims20
A method for detecting a mutant desmin protein comprising a phosphorylated D399Y mutation, the method comprising:
- obtaining a sample from a subject;
- and
- detecting the mutant desmin protein in the sample, wherein the mutant desmin protein comprises a tyrosine residue at position 399 that is phosphorylated.
A composition comprising a fragment of a mutant desmin protein, wherein the fragment comprises a phosphorylated tyrosine residue at position 399 corresponding to a D399Y mutation in wild-type desmin.
A construct comprising a polynucleotide encoding at least a portion of SEQ ID NO:
- 6 operably connected to a promoter, wherein the portion of SEQ ID NO:
- 6 comprises at least 8 amino acids and includes amino acid 399Y.
Dependencies are inferred from the claim text.